Lawsuit Accuses ChatGPT of Designing Fatal Drug Tapering

The parents of a woman who was found dead in her Seattle apartment have filed a complaint in San Francisco Superior Court against the Bay Area-based OpenAI and its CEO Sam Altman, accusing the defendants of engaging in the unauthorized practice of medicine and producing a defective product based on allegations that ChatGPT encouraged their daughter to taper off a life-saving epilepsy medication, causing her demise.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.